You are here: Industry Insights > Transaction

News List

The Boosting Bispecific Antibody Therapeutics Market: Market Size Exceeded USD3.5 Billion by 2021 PharmaSources/Yi
March 30, 2022
So far this year, there has been good news on the bispecific antibody therapeutics market.
Weekly Pharma News Review | PharmaSources.com (March 7 to 12) PharmaSources.com
March 16, 2022
The news review of this week is from March 7 to 12, covering a total of 20 pieces of information in 4 sections, i.e. review, R&D, business, and listing.
Westcot Ventures Corp. Announces Closing of Transaction of WPD Pharmaceuticals Sp. Z.o.o. firstwordpharma
December 24, 2019
Pursuant to the completion of the Transaction, the Company issued 67,000,000 common shares to the WPD Securityholders in exchange for 100% of the issued and outstanding securities of WPD. Upon completion of the Transaction, WPD has become a wholly-owned s
Bioasis Completes Bridge Financing Transaction firstwordpharma
December 24, 2019
Pursuant to the Bridge Financing, Bioasis issued a total of approximately CAD$696,000 unsecured debentures (the "Debentures") to a group of arm's length investors.
Permira Funds to Acquire Cambrex in $2.4B Transaction contractpharma
August 08, 2019
To back Cambrex in its next phase of growth.
Strides announces final closure of Arrow transaction expresspharma
July 11, 2019
Strides Pharma Global has announced the closure of its transaction with Arrow. The company disclosed that it has received AUD 300 million immediately at closing, while the balance AUD 94 million will be a deferred consideration backed by a secured interes
Evotec to Acquire Just Biotherapeutics in $90M Transaction contractpharma
May 29, 2019
Expands therapeutic offerings in areas such as oncology, CNS, pain, inflammation, metabolics, and infectious diseases.
Norgine Buys Merus Labs for $342M contractpharma
May 12, 2017
European specialist pharmaceutical company Norgine has acquired Merus Labs International for $342 million.